Breaks Categories: Stock Spotlights

WednesdayJan 24, 2018 11:26 am

CBDNewsBreaks – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Enhances Life by Uniting Nature and Science

An ongoing concern in North America, as reported by the Centers for Disease Control and Prevention, is that Americans are only taking advantage of preventive medical services about half as often as they should. Endeavoring to become a pioneer in preventative medicine, health science company PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) was founded on the belief that, in healthcare, prevention is the best policy, and that nature and science can unite to offer a range of innovative, untapped solutions to address unmet clinical needs. As quoted in a recent article: “PreveCeutical is taking a new look at…

Continue Reading

WednesdayJan 24, 2018 11:19 am

CBDNewsBreaks – Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQX: LXRP) DehydraTECH™ Platform Expands Portfolio

Food bioscience company Lexaria Bioscience’s (CSE: LXX) (OTCQB: LXRP) strategic focus for 2018 is on out-licensing its proprietary technology, DehydraTECH™. The company intends to out-license to third-party partners using a high margin royalty model. An article discussing the company’s drug delivery platform reads: “Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) is a research-driven company that has developed and out-licenses a patented drug delivery platform called DehydraTECH™ that changes the way active pharmaceutical ingredients (“APIs”) enter the body orally. According to a new report by Million Insights (http://cnw.fm/fGid9), the global API market is anticipated to reach $239.8 billion by 2025, with…

Continue Reading

WednesdayJan 24, 2018 11:12 am

CBDNewsBreaks – Earth Science Tech, Inc. (ETST) Reaches Noteworthy Achievements in 2017

Earth Science Tech, Inc. (OTC: ETST) is an innovative biotech company focused on production of cutting-edge industrial hemp and cannabidiol (“CBD”) products. An article discussing the company reads: “Earth Science Tech celebrated a significant, developmental year during 2017 by sharing its achievements in a condensed end-of-year report. Among the report’s highlights are the implementation of a development plan for the coming three years, which includes expanding into Canada and opening new manufacturing and shipping facilities. Of particular interest is the acquisition of Canna Inno Laboratories Inc., a company headquartered in Montreal, Quebec, Canada, which gives Earth Science Tech access to…

Continue Reading

TuesdayJan 23, 2018 12:34 pm

CBDNewsBreaks – ChineseInvestors.com, Inc. (CIIX) Remains Steadfast on Chinese Cryptocurrencies

ChineseInvestors.com (OTCQB: CIIX) is focusing on delivering profitability and value for its shareholders as the Chinese investment community seeks education about the unpredictable market of bitcoin and other cryptocurrencies. An article discussing the company reads: “Warren Wang, CEO of CIIX, said in a news release that the emerging middle class in China is expressing its desire to be educated about trading and investing in bitcoin and other cryptocurrencies. … CIIX, as a result, is doubling down on its commitment to bitcoin growth by offering a real-time daily video broadcast from the NYSE, targeted at the Chinese-speaking community in China and…

Continue Reading

FridayJan 19, 2018 12:33 pm

CBDNewsBreaks – Medical Cannabis Payment Solutions (REFG) Provides Secure Payment Processing Solution to Cannabis Industry

Medical Cannabis Payment Solutions (OTC: REFG) is on a mission to solve the cannabis industry’s lack of secure payment options. The cannabis-focused financial services company has created an end-to-end payment processing solution to serve both industry retailers and their customers. An article discussing the company reads: “A multi-billion dollar cash business invites headaches and trouble. Tax collection, payroll problems, bill payment, assaults and armed robbery all plague an industry that’s expected to exceed $37 billion in the U.S. by 2024. No other industry of this size suffers through such operational and logistical nightmares. …To solve these complex issues, Medical Cannabis…

Continue Reading

FridayJan 19, 2018 12:24 pm

CBDNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Eyes Bright Future Following 2017 Success

Lexaria Bioscience (CSE: LXX) (OTCQB: LXRP) demonstrated several transformative developments in 2017. The company’s Intellectual Property (“IP”) was strengthened, it was awarded broad patents, and it secured finances during the year. Now, Lexaria is concentrating on making 2018 an even more fruitful year. An article discussing the company’s recent progress reads: “The company’s stock has performed well over the last year and, given all the progress, may outperform in 2018. Lexaria up-listed to the larger, more recognized OTCQX market, and the company filed an S4 prospectus to re-domicile the company from the U.S. to Canada in an effort to exploit…

Continue Reading

FridayJan 19, 2018 11:50 am

CBDNewsBreaks – ChineseInvestors.com, Inc. (CIIX) Demonstrates Growth in Investor Relations Revenue; Intends to Expand Program Offerings

ChineseInvestors.com, Inc. (OTCQB: CIIX) recently demonstrated a large increase in its investor relations revenue in 1Q2018 and FY2017. The company remains focused on expanding program offerings for branding clients, including companies that trade in public markets such as the OTCQB Venture Market, NASDAQ and NYSE. An article discussing the company reads: “CIIX revenues from investor relations grew in 1Q2018 to $258,366, up 186 percent from the $90,312 it recorded in 1Q2017. In FY2017, CIIX investor relations sales grew to $808,362, 130 percent higher than the $351,615 in FY2016 (http://cnw.fm/3R8Ki). The company is expanding its program with such things as branding…

Continue Reading

FridayJan 19, 2018 11:41 am

CBDNewsBreaks – SingleSeed by SinglePoint, Inc. (SING) Set to Launch Payment Solution App

Specialized holding company SinglePoint, Inc. (OTC: SING) is set to launch its SingleSeed platform in the first quarter of 2018. The subsidiary was designed to provide a payment solution to the cannabis industry, a booming market forecasted to reach more than $63 billion by 2024. An article discussing the company reads: “SinglePoint will proceed with a full launch of its subsidiary, SingleSeed, during the first quarter of 2018 to provide a platform for retailers and consumers in the legal cannabis industry to process cryptocurrency payments. Based on blockchain technology, the SingleSeed platform is a proprietary payment processing app that enables…

Continue Reading

ThursdayJan 11, 2018 12:19 pm

CBDNewsBreaks – ChineseInvestors.com, Inc. (CIIX) Offers Holiday Promotions Recognizing Recreational Legalization in California

Market analysis company ChineseInvestors.com, Inc. (OTCQB: CIIX) subsidiary ChineseHempOil.com, Inc. is offering bitcoin as part of special holiday hemp oil packages in response to California’s recent legalization of recreational marijuana. An article discussing the company reads: “ChineseInvestors.com (OTCQB: CIIX) has combined its OptHempOil holiday promotions with premium incentives in the form of $50 and $150 in bitcoin. Bitcoin incentives are key to its promotion, offered through January 9, 2018, combining holiday packages with the cryptocurrency. It says the promotion is in recognition of California’s legalization of recreational marijuana in 2018 (http://cnw.fm/3nowB).” To view the full article, visit http://cnw.fm/8zn4Q About ChineseInvestors.com…

Continue Reading

WednesdayJan 10, 2018 11:55 am

CBDNewsBreaks – Skinvisible, Inc. (SKVI) and Quoin Pharmaceuticals to Provide Opioid-free Pain Relief Solution

Topical and transdermal product development company Skinvisible (OTCQB: SKVI), through its recently entered non-binding merger agreement with Quoin Pharmaceuticals Limited, is planning to create a solution to the opioid crisis that is currently plaguing America. An article discussing this reads: “In response to the substance abuse epidemic sweeping the nation, Congress passed the 21st Century Cures Act, which was signed into law by President Obama in December 2016. The legislation allocates over $1 billion to a variety of programs, some of which will attempt to wean patients away from addictive opium derivatives, a push unlikely to cause any degradation in…

Continue Reading